{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:25:05Z","timestamp":1789586705802,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142817","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T16:34:56Z","timestamp":1743870896000},"page":"142817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Falcipain-2: A review on structurally diverse non-peptide inhibitors"],"prefix":"10.1016","volume":"309","author":[{"given":"Vandana","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neera","family":"Raghav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.142817_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0010","unstructured":"W.H. Organization, World Malaria Report 2023, World Health Organization2023."},{"issue":"7572","key":"10.1016\/j.ijbiomac.2025.142817_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0020","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","article-title":"Mapping genetic markers of artemisinin resistance in plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis","volume":"3","author":"Kagoro","year":"2022","journal-title":"The Lancet Microbe"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0025","doi-asserted-by":"crossref","unstructured":"T.E. Wellems, J.M. S\u00e1, X.-z. Su, S.V. Connelly, A.C. Ellis, \u2018Artemisinin resistance\u2019: something new or old? Something of a misnomer?, Trends Parasitol. 36(9) (2020) 735\u2013744.","DOI":"10.1016\/j.pt.2020.05.013"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142817_bb0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bcp.14474","article-title":"Advances and roadblocks in the treatment of malaria","volume":"88","author":"Hanboonkunupakarn","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03565-2","article-title":"Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines","volume":"20","author":"Al Khaja","year":"2021","journal-title":"Malar. J."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142817_bb0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2352-4642(20)30127-9","article-title":"Treatment and prevention of malaria in children","volume":"4","author":"Ashley","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123195","article-title":"Curcumin or quercetin loaded nutriosomes as oral adjuvants for malaria infections","volume":"643","author":"Fulgheri","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140362","article-title":"Falcipain cysteine proteases of malaria parasites: an update","volume":"1868","author":"Rosenthal","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.142817_bb0055","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.2174\/0929867327666200730215316","article-title":"Falcipain-2 and falcipain-3 inhibitors as promising antimalarial agents","volume":"28","author":"Ettari","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0060","doi-asserted-by":"crossref","unstructured":"G.L. Patrick, Falcipains as Drug Targets in Antimalarial Therapy, Antimalarial Agents, Elsevier2020, pp. 271\u2013317.","DOI":"10.1016\/B978-0-08-101210-9.00008-1"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2021.12.080","article-title":"New insights of falcipain 2 structure from plasmodium falciparum 3D7 strain","volume":"590","author":"Chakraborty","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0070","doi-asserted-by":"crossref","unstructured":"P.J. Rosenthal, Falcipains, Handbook of Proteolytic Enzymes, Elsevier2013, pp. 1907\u20131912.","DOI":"10.1016\/B978-0-12-382219-2.00436-1"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijantimicag.2017.04.006","article-title":"Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges","volume":"50","author":"Roy","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0080","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/jm8013663","article-title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity","volume":"52","author":"Kerr","year":"2009","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.142817_bb0085","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2174\/0929867311320250003","article-title":"Development of plasmodium falciparum protease inhibitors in the past decade (2002\u22122012)","volume":"20","author":"Perez","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0090","doi-asserted-by":"crossref","unstructured":"B. Baraga\u00f1a, N.R. Norcross, C. Wilson, A. Porzelle, I. Hallyburton, R. Grimaldi, et al., Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy, Journal of Medicinal Chemistry. 59 (2016) 9672\u20139685. doi:https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00723.","DOI":"10.1021\/acs.jmedchem.6b00723"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0095","doi-asserted-by":"crossref","unstructured":"S. Pegoraro, M. Duffey, T.D. Otto, Y. Wang, R. R\u00f6semann, R. Baumgartner, et al., SC83288 is a clinical development candidate for the treatment of severe malaria, Nature Communications.8 (2017) 14193.doi:https:\/\/doi.org\/10.1038\/ncomms14193.","DOI":"10.1038\/ncomms15273"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142817_bb0100","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/092986711795328328","article-title":"Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria","volume":"18","author":"Teixeira","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142817_bb0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/1389450117666161221122432","article-title":"Targeting cysteine proteases from plasmodium falciparum: a general overview, rational drug design and computational approaches for drug discovery","volume":"19","author":"Bekono","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0110","first-page":"1","article-title":"To quest new targets of plasmodium parasite and their potential inhibitors to combat antimalarial drug resistance","author":"Biswas","year":"2024","journal-title":"J. Parasit. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/med.21979","article-title":"An overview on the antimalarial activity of 1, 2, 4-trioxanes, 1, 2, 4-trioxolanes and 1, 2, 4, 5-tetraoxanes","volume":"44","author":"Shukla","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/fcp.12974","article-title":"Antimalarial activities of benzothiazole analogs: a systematic review","volume":"38","author":"Tran","year":"2024","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.142817_bb0125","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1073\/pnas.90.8.3583","article-title":"Structure-based inhibitor design by using protein models for the development of antiparasitic agents","volume":"90","author":"Ring","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142817_bb0130","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.38.7.1470","article-title":"Licochalcone a, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite plasmodium falciparum and protects mice from P. Yoelii infection","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.142817_bb0135","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/jm00026a010","article-title":"In vitro antimalarial activity of chalcones and their derivatives","volume":"38","author":"Li","year":"1995","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142817_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/14756366.2014.920839","article-title":"Synthetic compounds from an in house library as inhibitors of falcipain-2 from plasmodium falciparum","volume":"30","author":"Bertoldo","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"34","key":"10.1016\/j.ijbiomac.2025.142817_bb0145","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1021\/acs.jpcb.9b05021","article-title":"Prediction of noncompetitive inhibitor binding mode reveals promising site for allosteric modulation of Falcipain-2","volume":"123","author":"Hernandez Gonzalez","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-3043-0","article-title":"The complex of plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site","volume":"18","author":"Machin","year":"2019","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142817_bb0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0223-5234(01)01245-4","article-title":"Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity","volume":"36","author":"Dom\u00ednguez","year":"2001","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142817_bb0160","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ejmech.2007.09.014","article-title":"Synthesis of novel substituted 1, 3-diaryl propenone derivatives and their antimalarial activity in vitro","volume":"43","author":"Mishra","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00044-008-9137-9","article-title":"Potent antimalarial activity of newly synthesized substituted chalcone analogs in vitro","volume":"18","author":"Awasthi","year":"2009","journal-title":"Med. Chem. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142817_bb0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2012.01383.x","article-title":"Antimalarial activity of newly synthesized chalcone derivatives in vitro","volume":"80","author":"Yadav","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jtbi.2016.05.019","article-title":"Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in plasmodium falciparum","volume":"403","author":"Thillainayagam","year":"2016","journal-title":"J. Theor. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142817_bb0180","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/jm058208o","article-title":"Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives","volume":"48","author":"Dom\u00ednguez","year":"2005","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.142817_bb0185","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1002\/slct.201701162","article-title":"In vitro antimalarial evaluation of Piperidine-and Piperazine-based Chalcones: inhibition of Falcipain-2 and Plasmepsin II Hemoglobinases activities from plasmodium falciparum","volume":"2","author":"Tiwari","year":"2017","journal-title":"ChemistrySelect"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.142817_bb0190","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1016\/j.bmcl.2010.05.069","article-title":"Synthesis of novel \u03b1-pyranochalcones and pyrazoline derivatives as plasmodium falciparum growth inhibitors","volume":"20","author":"Wanare","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0195","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00044-011-9694-1","article-title":"Design, synthesis and biological evaluation of some novel 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones as antimalarial agents","volume":"21","author":"Patel","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.142817_bb0200","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.bmcl.2018.03.058","article-title":"Designing novel inhibitors against falcipain-2 of plasmodium falciparum","volume":"28","author":"Pathak","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.142817_bb0205","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/ddr.21727","article-title":"Design, synthesis and biological evaluation of several aromatic substituted chalcones as antimalarial agents","volume":"81","author":"Gopinathan","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110379","article-title":"Novel hybrids of quinoline with pyrazolylchalcones as potential antimalarial agents: synthesis, biological evaluation, molecular docking and ADME prediction","volume":"373","author":"Kumar","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142817_bb0215","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.bmcl.2010.02.017","article-title":"Comparison of the antiplasmodial and falcipain-2 inhibitory activity of \u03b2-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0220","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14756366.2018.1564288","article-title":"Virtual design of novel plasmodium falciparum cysteine protease falcipain-2 hybrid lactone\u2013chalcone and isatin\u2013chalcone inhibitors probing the S2 active site pocket","volume":"34","author":"Allangba","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2014.07.087","article-title":"Synthesis, biological evaluation and molecular docking of novel chalcone\u2013coumarin hybrids as anticancer and antimalarial agents","volume":"85","author":"Pingaew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.142817_bb0230","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bmcl.2017.03.005","article-title":"Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives","volume":"27","author":"Vijayaraghavan","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.142817_bb0235","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1016\/j.bmc.2010.10.009","article-title":"Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds","volume":"18","author":"Guantai","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142817_bb0240","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone\u2013and chalcone\u2013chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies","volume":"54","author":"Guantai","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0245","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00044-014-1139-1","article-title":"Synthesis and antimalarial activity of quinoline-substituted furanone derivatives and their identification as selective falcipain-2 inhibitors","volume":"24","author":"Akhter","year":"2015","journal-title":"Med. Chem. Res."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.142817_bb0250","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1016\/j.bmc.2006.04.035","article-title":"Application of multicomponent reactions to antimalarial drug discovery. Part 2: new antiplasmodial and antitrypanosomal 4-aminoquinoline \u03b3-and \u03b4-lactams via a \u2018catch and release\u2019protocol","volume":"14","author":"Musonda","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"67","key":"10.1016\/j.ijbiomac.2025.142817_bb0255","doi-asserted-by":"crossref","first-page":"39410","DOI":"10.1039\/C9RA06571G","article-title":"Quinoline-triazole hybrids inhibit falcipain-2 and arrest the development of plasmodium falciparum at the trophozoite stage","volume":"9","author":"Singh","year":"2019","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142817_bb0260","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/07391102.2002.10506783","article-title":"Homology modeling of falcipain-2: validation, de novo ligand design and synthesis of novel inhibitors","volume":"19","author":"Sabnis","year":"2002","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142817_bb0265","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0968-0896(03)00117-2","article-title":"Structure-based approach to falcipain-2 inhibitors: synthesis and biological evaluation of 1, 6, 7-trisubstituted dihydroisoquinolines and isoquinolines","volume":"11","author":"Batra","year":"2003","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.142817_bb0270","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.bmc.2009.08.013","article-title":"Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors","volume":"17","author":"Micale","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142817_bb0275","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.arabjc.2014.09.007","article-title":"Novel thiosemicarbazone derivatives containing benzimidazole moiety: green synthesis and antimalarial activity","volume":"12","author":"Divatia","year":"2019","journal-title":"Arab. J. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.142817_bb0280","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/jm030549j","article-title":"Synthesis and structure\u2212 activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi","volume":"47","author":"Greenbaum","year":"2004","journal-title":"J. med. chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bmc.2006.09.055","article-title":"Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio) semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of plasmodium falciparum","volume":"15","author":"Chipeleme","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142817_bb0290","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11030-022-10594-3","article-title":"In silico investigation of falcipain-2 inhibition by hybrid benzimidazole-thiosemicarbazone antiplasmodial agents: a molecular docking, molecular dynamics simulation, and kinetics study","volume":"28","author":"Nkungli","year":"2024","journal-title":"Mol. Divers."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.142817_bb0295","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/S0960-894X(03)00756-X","article-title":"Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain","volume":"13","author":"Chiyanzu","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.142817_bb0300","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.bmc.2005.02.037","article-title":"Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives","volume":"13","author":"Chiyanzu","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.142817_bb0305","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0968-0896(96)00136-8","article-title":"Structure-based design of parasitic protease inhibitors","volume":"4","author":"Li","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-017-0344-7","article-title":"Design, synthesis, conformational and molecular docking study of some novel acyl hydrazone based molecular hybrids as antimalarial and antimicrobial agents","volume":"11","author":"Kumar","year":"2017","journal-title":"Chem. Cent. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0315","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12936-022-04266-8","article-title":"Evaluation of antimalarial potency of new pyrazole-hydrazine coupled to Schiff base derivatives","volume":"21","author":"Ibezim","year":"2022","journal-title":"Malar. J."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0320","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/9789815123647123020007","article-title":"Antimalarial Endoperoxides: from natural Sesquiterpene drugs to a rising generation of synthetic congeners","volume":"2","author":"Luisi","year":"2023","journal-title":"Terpenes"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142817_bb0325","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.3390\/molecules16064527","article-title":"Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives","volume":"16","author":"Liu","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0330","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s12272-012-0902-4","article-title":"Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors","volume":"35","author":"Liu","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0335","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00044-011-9854-3","article-title":"N 1-{4-[(10S)-Dihydroartemisinin-10-oxyl]} phenylmethylene-N 2-(2-methylquinoline-4-yl) hydrazine derivatives as antiplasmodial falcipain-2 inhibitors","volume":"21","author":"Luo","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0340","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/14756366.2017.1363742","article-title":"Novel series of 1, 2, 4-trioxane derivatives as antimalarial agents","volume":"32","author":"Rudrapal","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0345","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00044-017-2090-8","article-title":"Newer series of trioxane derivatives as potent antimalarial agents","volume":"27","author":"Rudrapal","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0350","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11094-019-02085-x","article-title":"Design and discovery of 3, 6-substituted 1, 2, 4, 5-tetraoxanes as new class of falcipain-2 inhibitors for antimalarial action","volume":"53","author":"Kumawat","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0355","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11094-021-02500-2","article-title":"Synthesis, antimalarial activity evaluation and molecular docking studies of some new substituted spiro-1, 2, 4, 5-tetraoxane derivatives","volume":"55","author":"Kumawat","year":"2021","journal-title":"Pharm. Chem. J."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.142817_bb0360","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1021\/jm801622x","article-title":"Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142817_bb0365","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/molecules14020785","article-title":"2-(3, 4-Dihydro-4-oxothieno [2, 3-d] pyrimidin-2-ylthio) acetamides as a new class of falcipain-2 inhibitors. 3. Design, synthesis and biological evaluation","volume":"14","author":"Zhu","year":"2009","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142817_bb0370","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.arabjc.2014.11.008","article-title":"Design, synthesis and evaluation of 2-(4-(substituted benzoyl)-1, 4-diazepan-1-yl)-N-phenylacetamide derivatives as a new class of falcipain-2 inhibitors","volume":"12","author":"Mahesh","year":"2019","journal-title":"Arab. J. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0375","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/molecules14010494","article-title":"2-Amido-3-(1 H-Indol-3-yl)-N-Substitued-Propanamides as a new class of Falcipain-2 inhibitors. 1. Design, synthesis, biological evaluation and binding model studies","volume":"14","author":"Zhu","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104514","article-title":"Quinoline carboxamide core moiety-based compounds inhibit P. Falciparum falcipain-2: design, synthesis and antimalarial efficacy studies","volume":"108","author":"Singh","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115155","article-title":"Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity","volume":"28","author":"Rana","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.fitote.2014.01.017","article-title":"Dietary flavonoids fisetin and myricetin: dual inhibitors of plasmodium falciparum falcipain-2 and plasmepsin II","volume":"94","author":"Jin","year":"2014","journal-title":"Fitoterapia"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142817_bb0395","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.bmcl.2014.01.074","article-title":"Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening","volume":"24","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142817_bb0400","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s11686-023-00711-z","article-title":"Potentials of terpenoids as inhibitors of multiple plasmodium falciparum protein drug targets","volume":"68","author":"Ishola","year":"2023","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.850176","article-title":"Target-based virtual screening of natural compounds identifies a potent antimalarial with selective falcipain-2 inhibitory activity","volume":"13","author":"Uddin","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.142817_bb0410","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.bmc.2013.04.047","article-title":"Falcipain-2 inhibition by suramin and suramin analogues","volume":"21","author":"Marques","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.142817_bb0415","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1039\/c1md00129a","article-title":"Design, synthesis and biological evaluation of novel benzothiazole and triazole analogs as falcipain inhibitors","volume":"2","author":"Shah","year":"2011","journal-title":"MedChemComm"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142817_bb0420","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/ci200029y","article-title":"Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library","volume":"51","author":"Shah","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0425","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/ci2005516","article-title":"Computer-aided drug design of falcipain inhibitors: virtual screening, structure\u2013activity relationships, hydration site thermodynamics, and reactivity analysis","volume":"52","author":"Shah","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142817_bb0430","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.dcmed.2021.12.004","article-title":"Rational drug design, synthesis, and biological evaluation of novel N-(2-arylaminophenyl)-2, 3-diphenylquinoxaline-6-sulfonamides as potential antimalarial, antifungal, and antibacterial agents","volume":"4","author":"Shntaif","year":"2021","journal-title":"Digit. Chin. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.142817_bb0435","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bmc.2015.02.029","article-title":"Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite","volume":"23","author":"Singh","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.142817_bb0440","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/jm100556b","article-title":"Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series","volume":"53","author":"Coteron","year":"2010","journal-title":"J. Med. Chem."},{"issue":"34","key":"10.1016\/j.ijbiomac.2025.142817_bb0445","doi-asserted-by":"crossref","first-page":"24725","DOI":"10.1039\/D4RA04370G","article-title":"Sulfonamide based pyrimidine derivatives combating plasmodium parasite by inhibiting falcipains-2 and falcipains-3 as antimalarial agents","volume":"14","author":"Rahman","year":"2024","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.142817_bb0450","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1021\/jm970266p","article-title":"Synthesis and antimalarial effects of phenothiazine inhibitors of a plasmodium falciparum cysteine protease","volume":"40","author":"Dom\u00ednguez","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0455","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3389\/fchem.2019.00534","article-title":"In silico guided drug repurposing: discovery of new competitive and non-competitive inhibitors of falcipain-2","volume":"7","author":"Alberca","year":"2019","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0460","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1021\/acs.jcim.1c01189","article-title":"Tetracycline derivatives inhibit plasmodial cysteine protease falcipain-2 through binding to a distal allosteric site","volume":"62","author":"Hernandez Gonzalez","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0465","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10822-021-00420-7","article-title":"In silico identification of noncompetitive inhibitors targeting an uncharacterized allosteric site of falcipain-2","volume":"35","author":"Hern\u00e1ndez Gonz\u00e1lez","year":"2021","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104142","article-title":"Identification and structure\u2013activity relationship (SAR) studies of carvacrol derivatives as potential antimalarial against plasmodium falciparum falcipain-2 protease","volume":"103","author":"Uddin","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.142817_bb0475","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1021\/jm0493717","article-title":"Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database","volume":"47","author":"Desai","year":"2004","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142817_bb0480","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/jm0505765","article-title":"Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory","volume":"49","author":"Desai","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142817_bb0485","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bmcl.2011.12.011","article-title":"Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent","volume":"22","author":"Huang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.142817_bb0490","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmc.2017.10.017","article-title":"Discovery of new antimalarial agents: second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely","volume":"25","author":"Chen","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142817_bb0495","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cclet.2017.11.041","article-title":"Novel dual inhibitors against FP-2 and PfDHFR as potential antimalarial agents: design, synthesis and biological evaluation","volume":"30","author":"Chen","year":"2019","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0500","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00044-005-0126-y","article-title":"Design, synthesis and evaluation of trisubstituted thiazoles targeting plasmodium falciparum cysteine proteases","volume":"14","author":"Goud","year":"2005","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142817_bb0505","first-page":"666","article-title":"Quinoid compounds cause inhibition of falcipain 2, and arrest plasmodium falciparum growth in vitro","volume":"33","author":"Duran-Lengua","year":"2014","journal-title":"Lat. Am. J. Pharm."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.142817_bb0510","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.bmc.2012.09.008","article-title":"Pyrido [1, 2-a] pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors","volume":"20","author":"Mane","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142817_bb0515","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejmech.2014.11.061","article-title":"Synthesis and structure\u2013activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the plasmodium falciparum cysteine protease falcipain-2","volume":"90","author":"Sharma","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142817_bb0520","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1039\/D3MD00490B","article-title":"Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors","volume":"15","author":"Madhav","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.142817_bb0525","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1080\/07391102.2022.2130984","article-title":"Screening of potential antiplasmodial agents targeting cysteine protease-Falcipain 2: a computational pipeline","volume":"41","author":"Verma","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025033690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025033690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:05:42Z","timestamp":1782903942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025033690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":105,"alternative-id":["S0141813025033690"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142817","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Falcipain-2: A review on structurally diverse non-peptide inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142817"}}